Wealth Enhancement Trust Services’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Other funds holding IOVA
Wealth Enhancement Trust Services's IOVA Position: Q3 2026 in Review
Wealth Enhancement Trust Services reduced its Iovance Biotherapeutics (IOVA) stake by 57% in Q3 2026, selling an estimated $38.7K and leaving 4,000 shares worth $59.3K. The position accounts for 0.01% of the portfolio, ranked #432.
Wealth Enhancement Trust Services first reported a position in IOVA in Q4 2025 and has held it in 4 quarters since. 335 funds tracked by Wall St. Rank hold IOVA as of Q3 2026.
- Wealth Enhancement Trust Services held 4,000 shares of Iovance Biotherapeutics worth $59.3K as of Q3 2026.
- Wealth Enhancement Trust Services sold 5,404 Iovance Biotherapeutics shares in Q3 2026, an estimated $38.7K.
- Iovance Biotherapeutics made up 0.01% of Wealth Enhancement Trust Services's portfolio in Q3 2026, its #432 holding.
- Wealth Enhancement Trust Services first reported a position in Iovance Biotherapeutics in Q4 2025 and has held it in 4 quarters since.
- 335 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2026.
Based on Wealth Enhancement Trust Services's 13F filing for Q3 2026, filed 7 Oct 2026.